Physician profile
Patrick Thol Pak
NPI 1861611386
$493.83
in general payments reported to CMS, 2019-2025
12 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.69 · 2022: $36.76 · 2023: $38.32 · 2024: $127 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.79 | 2024-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $59.16 | 2024 | Zepbound |
| Dexcom, INC. | $54.19 | 2024-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $52.86 | 2021-2025 | Arexvy, Shingrix, Bexsero |
| Novo Nordisk INC | $52.43 | 2022-2025 | Wegovy |
| Redhill Biopharma INC. | $33.78 | 2025 | Talicia |
| Merck Sharp & Dohme LLC | $24.26 | 2022 | |
| Sanofi Pasteur INC. | $22.49 | 2025 | |
| Corcept Therapeutics | $19.25 | 2025 | Korlym |
| Sumitomo Pharma America, INC. | $17.34 | 2024 | Gemtesa |
| Phadia US INC. | $17.09 | 2025 | Immunocap |
| Hologic Sales and Service, LLC | $16.19 | 2023 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.